Clinical Trial Update: Fibromyalgia of Less Than One Year Duration. Study of Pregabalin [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating pregabalin for fibromyalgia of less than one year duration was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Lyrica (Pregabalin)

Snippet

Sponsor: Newton-Wellesley Hospital | Conditions: Fibromyalgia | Phase 4 | Status: WITHDRAWN